NAVIDEA BIOPHARMACEUTICALS, INC. 4
4 · NAVIDEA BIOPHARMACEUTICALS, INC. · Filed Feb 29, 2016
Insider Transaction Report
Form 4
LARSON BRENT L
VP Finance and CFO
Transactions
- Award
Stock Option (Right to Buy)
2016-02-25+54,501→ 54,501 totalExercise: $0.98From: 2016-02-26Exp: 2026-02-25→ Common Stock (54,501 underlying)
Footnotes (1)
- [F1]Granted in lieu of cash bonus under 2015 bonus plan.